Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2001-1-4
pubmed:abstractText
Serum CA125 (sCA125) was recently reported to be of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma (NHL). This report aims to investigate the prognostic value of a new serologic index combining sCA125 and LDH serum levels.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0923-7534
pubmed:author
pubmed:issnType
Print
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1485-91
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:11142490-Adult, pubmed-meshheading:11142490-Aged, pubmed-meshheading:11142490-CA-125 Antigen, pubmed-meshheading:11142490-Disease-Free Survival, pubmed-meshheading:11142490-Female, pubmed-meshheading:11142490-Follow-Up Studies, pubmed-meshheading:11142490-Humans, pubmed-meshheading:11142490-L-Lactate Dehydrogenase, pubmed-meshheading:11142490-Life Tables, pubmed-meshheading:11142490-Lymphoma, Non-Hodgkin, pubmed-meshheading:11142490-Male, pubmed-meshheading:11142490-Middle Aged, pubmed-meshheading:11142490-Neoplasm Proteins, pubmed-meshheading:11142490-Neoplasm Staging, pubmed-meshheading:11142490-Prognosis, pubmed-meshheading:11142490-Remission Induction, pubmed-meshheading:11142490-Severity of Illness Index, pubmed-meshheading:11142490-Survival Analysis, pubmed-meshheading:11142490-Treatment Outcome, pubmed-meshheading:11142490-Tumor Markers, Biological, pubmed-meshheading:11142490-beta 2-Microglobulin
pubmed:year
2000
pubmed:articleTitle
A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels.
pubmed:affiliation
Department of Hematology/Oncology, H pital Bretonneau, Tours, France. l.Benboubker@bretonneau.chu-tours.fr
pubmed:publicationType
Journal Article, Comparative Study, Evaluation Studies